Marksans Pharma’s arm gets EIR from USFDA

03 Nov 2023 Evaluate

Marksans Pharma’s wholly owned subsidiary -- Time-Cap Laboratories, Inc. has received Establishment Inspection Report (EIR) from US Food & Drugs Administration (USFDA) for audit conducted in October 2023. No 483's were issued during the Audit.

Earlier, German health authorities had conducted inspection at Marksans Pharma’s newly acquired manufacturing facility located at Verna Industrial Estate, Verna, Goa. The Authorities had not found any critical/major observations but have few recommendations/ minor points which the Company is committed to implement immediately.

Marksans Pharma together with its subsidiaries operates as an integrated international pharmaceutical company. The company’s business is distribution of pharmaceutical products.


Marksans Pharma Share Price

183.95 -3.95 (-2.10%)
05-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1804.95
Dr. Reddys Lab 1275.05
Cipla 1520.55
Zydus Lifesciences 931.45
Lupin 2097.65
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×